Cat. #153999
Anti-CEACAM21 [1E4]
Cat. #: 153999
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Human CEACAM 21
Class: Monoclonal
Application: ELISA ; FACS ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Bernhard B. Singer
Institute: LeukoCom
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CEACAM21 [1E4]
- Research fields: Cancer;Cell biology
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; FACS ; WB
- Immunogen: Recombinant soluble human CEACAM 21-Fc produced in HEK293 Transfectants
- Isotype: IgG1 kappa
- Myeloma used: NS1/0
Target Details
- Target: Human CEACAM 21
Applications
- Application: ELISA ; FACS ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Tchoupa et al. 2014. Cell Commun Signal. 12:27. PMID: 24735478.
- Signaling by epithelial members of the CEACAM family - mucosal docking sites for pathogenic bacteria.
- Genetics of sputum gene expression in chronic obstructive pulmonary disease.
- Qiu et al. 2011. PLoS One. 6(9):e24395. PMID: 21949713.
- Zebhauser et al. 2005. Genomics. 86(5):566-80. PMID: 16139472.
- Identification of a novel group of evolutionarily conserved members within the rapidly diverging murine Cea family.
- Fukuda, I., Yamakado, M. & Kiyose, H. Journal of Medical Systems (1998) 22: 89.
